{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:38:58Z","timestamp":1792618738456,"version":"4.5.0"},"reference-count":9,"publisher":"Massachusetts Medical Society","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2026,10,22]]},"DOI":"10.1056\/nejme2612343","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:00:21Z","timestamp":1792616421000},"page":"1643-1644","source":"Crossref","is-referenced-by-count":0,"title":["Role for Factor XIa Inhibitors after an Acute Coronary Syndrome Event"],"prefix":"10.1056","volume":"395","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5131-3694","authenticated-orcid":false,"given":"Debabrata","family":"Mukherjee","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Texas Tech University Health Sciences Center, El Paso"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.15420\/usc.2022.10"},{"issue":"13","key":"e_1_3_3_3_2","first-page":"e771","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines.","volume":"151","author":"Rao SV","year":"2025","unstructured":"Rao SV, O\u2019Donoghue ML, Ruel M, et al. 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation 2025;151(13):e771-e862.40014670","journal-title":"Circulation"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112277"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X231206778"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.11.057"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2608717"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2407105"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2513880"},{"key":"e_1_3_3_10_2","first-page":"493","article-title":"Factor XI\/XIa inhibitors: promising agents for the secondary prevention of ischemic stroke.","volume":"42","author":"Atmaca MM","year":"2025","unstructured":"Atmaca MM. Factor XI\/XIa inhibitors: promising agents for the secondary prevention of ischemic stroke. Balkan Med J 2025;42:493-494.40999759","journal-title":"Balkan Med J"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMe2612343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:00:34Z","timestamp":1792616434000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMe2612343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":9,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026,10,22]]}},"alternative-id":["10.1056\/NEJMe2612343"],"URL":"https:\/\/doi.org\/10.1056\/nejme2612343","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]}}}